Title of article
A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial
Author/Authors
John A. Ormiston، نويسنده , , Patrick W Serruys، نويسنده , , Evelyn Regar، نويسنده , , Dariusz Dudek، نويسنده , , Leif Thuesen، نويسنده , , Mark W.I. Webster، نويسنده , , Yoshinobu Onuma، نويسنده , , Hector M Garcia-Garcia، نويسنده , , Robert McGreevy، نويسنده , , Susan Veldhof، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2008
Pages
9
From page
899
To page
907
Abstract
Background
A fully bioabsorbable drug-eluting coronary stent that scaffolds the vessel wall when needed and then disappears once the acute recoil and constrictive remodelling processes have subsided has theoretical advantages. The bioasorbable everolimus-
Journal title
The Lancet
Serial Year
2008
Journal title
The Lancet
Record number
592627
Link To Document